The information contained within is for educational and informational purposes ONLY. It is not intended nor should it be considered an invitation or inducement to buy or sell a security or securities noted within nor should it be viewed as a communication intended to persuade or incite you to buy or sell security or securities noted within. Any commentary provided is the opinion of the author and should not be considered a personalised recommendation. The information contained within should not be a person's sole basis for making an investment decision. Please contact your financial professional before making an investment decision.
This fund remains one of our favourite health-care sector offerings.
BlackRock World Healthscience is a worthy option for investors seeking healthcare exposure.
The ACM International Health Care fund is one of the least volatile in the Life Sciences category...
The ABN AMRO Biotech fund invests worldwide in biotechnology shares. This is a risky sector but i...
Investing in the Pictet Biotech fund could be attractive considering the tremendous growth potent...
Mining companies are operating in a challenging environment but could now be the time to top up o...
THE WEEK: Morningstar columnist Rodney Hobson provides two pieces of advice to George Osborne, an...
Businesses that have competitive advantages within their industry are good candidates for dividen...
Morningstar reveals the top 10 best performers over the last five years
Morningstar OBSR reveals the top funds for investors seeking exposure to European equities
On April 3 we get the release of the latest euro area CPI data for March. Will inflation keep fal...
Current valuation for the UK company is propelled by an exaggerated artificial intelligence narra...
Easter is here, and with it different trading times. Read our guide to when the London Stock Exch...
The price of cocoa beans has surged to over $10,000, but which chocolate producers are set to gai...
Morningstar director of manager research Monika Calay shares two ETFs and one open-ended fund tha...